Nanette K. Wenger - Concepedia

Author

Nanette K. Wenger

Also Known As

Gerald F. Watts, H Swan, Janet K Snell-Bergeon, Janet Snell-Bergeon, Levin, Thomas N., Matthew T. Brown, N K WENGER, N K Wenger, N Wenger, N. K. WENGER

715

Publications

66.7K

Citations

H-Index

227

Concepts

All Affiliations

Emory University University of California, San Francisco Grady Memorial Hospital Pfizer (United States)University of Alabama at Birmingham

About

Nanette K. Wenger is an author at Emory University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	55	103	26.1K
2	Public Health	36	55	16.7K
3	Health Sciences	14	17	940
4	Nursing	6	6	248
5	Education	1	1	66

Nanette K. Wenger

169

Publications

52.8K

Citations

H-Index

Page 1

	Year	Citations
2023 ESC Guidelines for the management of acute coronary syndromes Robert A. Byrne, Xavier Rosselló, J J Coughlan, European Heart Journal	2023	3.8K
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes Ezra A. Amsterdam, Nanette K. Wenger, Ralph G. Brindis, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyCoronary Artery DiseasePatient Safety	2014	3.6K
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease John C. LaRosa, Scott M. Grundy, David D. Waters, New England Journal of Medicine	2005	3.5K
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow, Data Archiving and Networked Services (DANS) HemodialysisUrologyRenal DiseaseRenal FunctionOrthopaedic Surgery	2003	2.5K
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease Paul M. Thompson, David M. Büchner, Ileana L. Piña, Circulation	2003	2.1K
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update Lori Mosca, Emelia J. Benjamin, Kathy Berra, Circulation Preventive MedicineCardiovascular DiseaseCoronary Artery DiseaseEffectiveness-based GuidelinesHealth Prevention	2011	2.1K
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy Deborah Grady, David Herrington, Vera Bittner, JAMA	2002	1.9K
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults Philip Greenland, Joseph S. Alpert, George A. Beller, Circulation	2010	1.9K
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Circulation	2007	1.9K
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin Paul L. Canner, Kenneth G. Berge, Nanette K. Wenger, Journal of the American College of Cardiology Cardiovascular DiseaseHealth PolicyLong-term BenefitCardiovascular PharmacologyFifteen Year Mortality	1986	1.8K

Page 1